The 2025 Workshop Program (below) is under development.
Program is subject to change.
FRIDAY , JULY 18
Workshop Pretest available, to be completed by 2 p.m. on Sunday, July 20
SUNDAY, JULY 20
Registration
2-8 pm
Faculty Meeting
4:15-5:15 pm
Welcome/Overview
5:15-5:30 pm
- Julie M. Vose, University of Nebraska Medical Center, Omaha, Nebraska
- Wendy B. London, Dana-Farber Cancer Institute and Boston Children’s Hospital, Boston, Massachusetts
- Timothy A. Yap, The University of Texas Anderson Cancer Center, Houston, Texas
Lecture Session 1
5:30-6 pm
- Answering Important Questions: From Hypothesis to Analysis
Wendy B. London, Dana-Farber Cancer Institute and Boston Children’s Hospital, Boston, Massachusetts
Protocol Development Group Session 1 / Grab and Go Dinner
6-8 pm
MONDAY, JULY 21
Breakfast
7-8 am
Lecture Session 2
8-9:50 am
- Phase I Trial Designs and Questions
Alex A. Adjei, Cleveland Clinic, Cleveland, OH and Shing Lee, Columbia University, New York, New York - Phase II Trial Designs, Questions, and Objectives
Maha Hussain, Northwestern University Feinberg School of Medicine, Chicago, Illinois - Questions / Panel Discussion
- TAKE NOTE: How will this session be applied to your protocol
Break
9:50-10 am
Lecture Session 3
10-11:40 am
- Combination and Multimodality Trials
Hope Rugo, City of Hope, Duarte Cancer Center, Duarte, California
Amir Jazaeri, University of Texas, MD Anderson Cancer Center, Houston Texas
Adam P. Dicker, Thomas Jefferson University, Philadelphia, Pennsylvania - Project Optimus: Reforming Dose Optimization and Dose Selection
Timothy A. Yap, The University of Texas Anderson Cancer Center, Houston, Texas - Questions / Panel Discussion
- TAKE NOTE: How will this session be applied to your protocol
Group Writing Session 1
11:40 am – 12:30 pm
Lunch
12-1:30 pm
Protocol Development Group Session 2 / Grab and Go Lunch
12:30-2:45 pm
Office Hours 1: Biostatistician Faculty Only (Prescheduled Appointments, with PDG Biostatistician Faculty)
3-5:15 pm
Dinner (Including Team-Building Exercise)
7-9 pm
ASSIGNMENT DUE: PROTOCOL TEMPLATE
8 pm
TUESDAY, JULY 22
Breakfast
7-8 am
Lecture Session 4
8-9:45 am
- Incorporation of Biological Correlative Studies into Early Clinical Trials
Jordi Rodon Ahnert, The University of Texas MD Anderson Cancer Center, Houston, Texas - Feasibility and Reproducibility in Biomarker Studies
Kurt A. Schalper, Yale University, New Haven, Connecticut - Statistical Aspects of Correlative Studies
Statistician to be announced - Questions / Panel Discussion
- TAKE NOTE: How will this session be applied to your protocol
Break
9:40-10 am
Lecture Session 5
10-11:15 am
- Imaging in the Era of Targeted Therapy and Immunotherapy
Ammar Chaudhry, AstraZeneca, Yorba Linda, California - Special Considerations in the Design of Immunotherapy Studies
Ryan Sullivan, Harvard Medical School/Massachusetts General Hospital, Boston, Massachusetts - Questions / Panel Discussion
- TAKE NOTE: How will this session be applied to your protocol
Group Writing Session 2
11:15 am-12 pm
Lunch
12-1:15 pm
Protocol Development Group Session 3
1:15-4 pm
Office Hours 2: Statistical Design and Protocol Related Questions
4:15-6:30 pm
Grab and Go Dinner
5:30-7 pm
ASSIGNMENT DUE: STATISTICAL DESIGN
7 pm
WEDNESDAY, JULY 23
Breakfast
7-8 am
Small Group Discussion Sessions 1-3
8-9 am
- Elements of Artificial Intelligence
Carole Baas, NCI Physical Sciences in Oncology Network, Southlake, Texas
Ammar Chaudhry, AstraZeneca, Yorba Linda, California
John Rice, University of Michigan, Ann Arbor, Michigan - Symptom Management, Patient Reported Outcomes, and Quality of Life
Vijaya R. Bhatt, University of Nebraska Medical Center, Omaha, Nebraska
Jill Feldman, EGFR Resisters, Evanston, Illinois
Sujata Patil, Cleveland Clinic, Cleveland, Ohio - Laboratory Correlates, ctDNA, and Liquid Biopsy
Maura N. Dickler, Genentech, South San Francisco, California
Josh Mailman, NorCal CarciNET Community, Oakland, California
Lindsay Renfro, University of Southern California, Los Angeles, California
Break
9-9:15 am
Small Group Discussion Sessions 4-6
9:15-10:15 am
- Elements of Artificial Intelligence
Carole Baas, NCI Physical Sciences in Oncology Network, Southlake, Texas
Ammar Chaudhry, AstraZeneca, Yorba Linda, California
John Rice, University of Michigan, Ann Arbor, Michigan - Symptom Management, Patient Reported Outcomes, and Quality of Life
Vijaya R. Bhatt, University of Nebraska Medical Center, Omaha, Nebraska
Jill Feldman, EGFR Resisters, Evanston, Illinois
Sujata Patil, Cleveland Clinic, Cleveland, Ohio - Laboratory Correlates, ctDNA, and Liquid Biopsy
Maura N. Dickler, Genentech, South San Francisco, California
Josh Mailman, NorCal CarciNET Community, Oakland, California
Lindsay Renfro, University of Southern California, Los Angeles, California
Break / Group Photo
10:15-10:45 am
Protocol Development Group Session 4
10:45 am-1:15 pm
Lunch
1:15 pm-2:15 pm
Office Hours 3: Protocol Related Questions
2:15 pm-4:30 pm
Free Time / Dinner on Own
2:30 pm
ASSIGNMENT DUE: PROTOCOL DRAFTS
7 pm
THURSDAY, JULY 24
Breakfast
7-8 am
Lecture Session 6
8-9:45 am
- You’re in Charge: Investigator Responsibilities
John P. Leonard, NYU Langone, New York, New York - How to Pay for Your Trial
Richard D. Carvajal, Northwell Health Cancer Institute, New York, New York - Everything You Need to Know About Clinical Trial Ethics and Informed Consent
Diana T. Chingos, DTC Consulting, Los Angeles, California - Questions / Panel Discussion
- TAKE NOTE: How will this session be applied to your protocol
Break
9:45-10 am
Protocol Development Group Session 5
10 am – 12:30 pm
Lunch
12:30-1:30 pm
Independent Study Time/Dinner on Own
3-7 pm
Office Hours 4: Informed Consent and Protocol Related Questions
1:30-3:30 pm
Free Time / Dinner on Own
3:30 pm
ASSIGNMENT DUE: INFORMED CONSENT DOCUMENTS
7 pm
FRIDAY, JULY 25
Breakfast
7-8:30 am
Faculty Meeting (Faculty Only)
7-8 am
Lecture Session 7
8:30-10:15 am
- Successful Grantsmanship
Mark Krailo, Children’s Oncology Group, Los Angeles, California - Data Collection: It’s All in the Data
To be announced - Reporting and Presenting Results
Tari King, Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center, Boston, Massachusetts
Mary W. Redman, Fred Hutchinson Cancer Center, Seattle, Washington - Questions / Panel Discussion
Protocol Development Group Session 6
10:30 am-12 pm
Lunch (Boxed)
12-1:30 pm
Office Hours 5: Professional Development: Careers, Funding, and Publications
1:30-2:45 pm
Administration of Post-test
1-7 pm
Free Time
1:30-7 pm
Optional Networking Reception: Women in Hematology/Oncology
5-6 pm
ASSIGNMENT DUE: FINAL PROTOCOLS, INFORMED CONSENT FORMS, and ALL WORKSHOP EVALUATIONS
7 pm
Closing Reception / Banquet / Dance
7-11 pm
SATURDAY, JULY 26
Departure (on own)